Slingshot Insights | G9 U.f Overview

G9U.F Overview

Upcoming Projects (G9U.F)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (G9U.F)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (G9U.F)

Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Tickers: TKPYY, G9U.F
Occurred on: Aug 02, 2016
TiGenix submits MAA to EMA for Cx601 for the treatment of complex perianal fistulas in Crohn’s disease patients
Ticker: G9U.F
Occurred on: Mar 02, 2016

Strategic Initiatives (G9U.F)

Don’t see a strategic initiative related to the company you care about? Create your own!